ArticleTranslational gastroenterology and hepatology2017
No benefit from ramucirumab in first-line chemotherapy?
Seiichiro Mitani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleTranslational gastroenterology and hepatology2017
Seiichiro Mitani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.